Refine Results
- Content Type
-
Content Type
- Analysis Platform
-
Product
- Language
-
Language
Applied Filters
This application note describes the use of human primary hepatocytes in the context of the Agilent Seahorse XF Mito Tox assay, including assay optimization,
- Publication Part Number: 5994-6476EN
- Created: 08 Aug 2023
- 2 MB
This document provides instruction on how to perform FCCP optimization using the Agilent Seahorse XF Cell Mito Stress Test with the Agilent Seahorse XF Pro Analyzer
- Publication Part Number: 5994-4807EN
- Created: 29 Apr 2022
- 367 KB
Agilent Seahorse XF Mito Tox Assay Kit Quick Starter Guide outlines the key steps to perform the XF Mito Tox assay
- Publication Part Number: 5994-4808EN
- Created: 29 Apr 2022
- 218 KB
Agilent Seahorse XF Mito Tox Assay Kit User Guide
- Publication Part Number: 5994-3715EN
- Created: 29 Apr 2022
- 6 MB
| Chinese (Simplified) (China) | Complete (PDF) |
|---|
Learn about a customized workflow to standardize the identification/investigation of mitochondrial toxicity using Agilent Seahorse XF technology.
- Publication Part Number: 5994-4778EN
- Created: 27 Apr 2022
- 3 MB
Anti-cancer drugs exploiting metabolic vulnerability were screened and evaluated by using an integrated workflow measuring cellular energy metabolism andcytotoxicity
- Publication Part Number: AACR 3071
- Created: 25 Apr 2025
- 366 KB
This study aims to optimize and validate a drug safety testing workflow that integrates mitochondrial toxicity assessment using Seahorse XF analysis solution with cell viability assessment via the xCELLigence RTCA platform.
- Created: 19 Mar 2025
- 437 KB
Poster from SOT 2024. Drug safety testing can be optimized using HUREL micro livers on two Agilent cell analysis platforms: Seahorse XF Pro and xCELLigence RTCA Analyzer.
- Created: 08 May 2024
- 895 KB
This case study illustrates the importance of mitochondrial toxicity assessment in drug discovery and development and provides insights into the methods used to prevent toxic compounds from slipping through, early in the drug discovery process.
- Publication Part Number: 5994-4810EN
- Created: 15 Sep 2023
- 233 KB
An optimized workflow that uses human primary hepatocytes with Agilent Seahorse XF mito tox assay to assess drug induced liver toxicity is described in the poster.
- Publication Part Number: 5994-5991EN
- Created: 04 Apr 2023
- 883 KB
Learn about the principle and parameter calculations in the Agilent Seahorse XF Mito Tox assay solution used to assess mitochondrial toxicity
- Publication Part Number: 5994-4732EN
- Created: 18 Jan 2023
- 2 MB
Learn about Agilent Seahorse XF mito tox assay that provides a standardized workflow to assess mitochondrial toxicity
- Created: 04 Apr 2022
- 1 MB
Direct functional measurements for assessing mitochondrial toxicity with high sensitivity and specificity.
- Publication Part Number: 5994-4319EN
- Created: 03 Jan 2022
- 335 KB
Direct functional measurements for assessing mitochondrial toxicity with high sensitivity and specificity.
- Publication Part Number: 5994-4320EN
- Created: 03 Jan 2022
- 594 KB
安捷倫 Seahorse XF 線粒體毒性測定試劑盒快速入門指南概述了進(jìn)行 XF 線粒體毒性檢測的關(guān)鍵步驟
- Publication Part Number: 5994-4808ZHCN
- Created: 29 Apr 2022
- 227 KB